Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs in Interstitial Pulmonary Fibrosis
NCT03187431Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of autologous bone-marrow mesenchymal stem cells in pulmonary fibrosis (PF), sponsored by Assiut University. Primary endpoint: Number of participants with treatment related side effects at 6 months. Status: unknown.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT03187431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187431.